Analysis of the transporter’s expression in CLCOs revealed that SLC51A/B and ABCC3 were down-regulated by CPZ treatment, which might contribute to CPZ induced cholestasis in cholangiocytes. This evidence concerns the gene SLC51A and cholestasis.